Results

1–5 of 5 results for Suprachoroidal Triamcinolone

Efficacy of Suprachoroidal Triamcinolone Acetonide Injectable Suspension in the Treatment of Macular Edema in Patients With Chronic Uveitis
Christopher R Henry, MD
Annual Meeting Talks
2022
Suprachoroidal Triamcinolone Acetonide Injectable Suspension for Uveitic Macular Edema: Outcomes in PEACHTREE by Baseline Disease Characteristics
On Demand Cases, Courses, and Papers
2022
Office Based Flicker ERG for Monitoring the Course of CRVO and HRVO Treated With Intravitreal Anti-VEGF and Suprachoroidal Triamcinolone Therapy
John J. Wroblewski, MD
Annual Meeting Talks
2021
Intraocular Pressure Following Administration of Suprachoroidal Triamcinolone Acetonide Suspension: Results From the Phase 3 PEACHTREE Clinical Trial
Quan Dong Nguyen, MD, MSc, FARVO, FASRS
Annual Meeting Talks
2020
Suprachoroidal Triamcinolone Acetonide with and without Intravitreal Aflibercept for Diabetic Macular Edema: Results of the 6-Month Prospective, Phase 1/2 Hulk Study
Charles C Wykoff, MD, PhD, FASRS
Updates from the Field
2017